Company
Saniona AB
Headquarters: Glostrup, Denmark
Employees: 53
CEO: Mr. Rami Levin
Market Cap
€23.1 Million
EUR as of Jan. 1, 2024
US$25.5 Million
Top Competitors by Market Capitalization
Industry: Biotechnology
| Company | Market Cap (USD) |
|---|---|
| Novo Nordisk | $461.52 B |
| Vertex Pharmaceuticals Incorporated | $107.23 B |
| Regeneron Pharmaceuticals, Inc. | $100.01 B |
| CSL Limited | $94.74 B |
| Marinomed Biotech AG | $73.23 B |
Sector:
| Company | Market Cap (USD) |
|---|---|
| Lilly | $586.39 B |
| UnitedHealth Group | $504.47 B |
| Novo Nordisk | $461.52 B |
| Johnson & Johnson | $387.50 B |
| Merck | $296.51 B |
Detailed Description
Saniona AB (publ), a research and development company, engages in the development of drugs for diseases of the central nervous system and eating disorders in Denmark. The company's products include Tesofensine, a triple monoamine reuptake inhibitor; Tesomet, a fix-dose combination of tesofensine and metoprolol that has completed the Phase 2 clinical trials for the treatment of prader-willi syndrome and hypothalamic obesity; and CAD-1883 for movement disorders. It is also developing SAN711 for rare neuropathic disorders, which is in Phase 1; SAN903 that is in preclinical stage for rare inflammatory/fibrotic disorders; and Boehringer Ingelheim program for schizophrenia. In addition, it has a portfolio of various drug candidates in pre-clinical and clinical stages. Saniona AB (publ) was founded in 2011 and is headquartered in Glostrup, Denmark.
Top 1-year algo backtest: +284.14%
$10,000 in April 2023 would now be $38,414 by following this algorithm daily at market close.
Boost your stocks returns with Disfold AI... Now!
Try Disfold AI for FREE
Stocks & Indices
Saniona AB has the following listings and related stock indices.
Stock: FSX: 30S wb_incandescent
Stock: OMX: SANION wb_incandescent